Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 52 (PPIAP52)

Target: PPIAP52
Molecular classification: Other

Overview

Peptidylprolyl isomerase A pseudogene 52 (PPIAP52) is annotated as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they are generally not transcribed into functional proteins or structurally incomplete. There is no evidence that PPIAP52 encodes an active enzyme, receptor, or protein, nor any evidence linking it to disease roles, drug interactions, or recognized biomarker status. As a result, it is not considered a therapeutic target.

Other names: PPIAP52

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 52 (PPIAP52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 52 (PPIAP52).

Explore the full profile